An investigation of calcium carbonate core-shell particles for incorporation of
Actinium
Alpha therapy
Calcium carbonate
Core-shell particles
Daughter isotopes
Radiolabeling
Radionuclide retention
SPECT
in vivo biodistribution
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 02 2021
10 02 2021
Historique:
received:
04
09
2020
revised:
04
12
2020
accepted:
04
01
2021
pubmed:
12
1
2021
medline:
8
7
2021
entrez:
11
1
2021
Statut:
ppublish
Résumé
Alpha therapy provides an outstanding prospect in the treatment of recalcitrant and micrometastatic cancers. However, side effects on the normal tissues and organs (especially, kidneys) due to the release of daughter isotopes from α-emitters remain a bottleneck. In this work, calcium carbonate core-shell particles of different sizes were considered as isotope carriers for encapsulation of
Identifiants
pubmed: 33428985
pii: S0168-3659(21)00017-1
doi: 10.1016/j.jconrel.2021.01.008
pii:
doi:
Substances chimiques
Radioisotopes
0
Calcium Carbonate
H0G9379FGK
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
726-737Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.